Approach to a dysmorphic child

Algorithm

%%{init: {"themeVariables": { "lineWidth": "3px", "lineColor": "#000000" } }}%%
graph TD
    classDef step1 fill:#E6F0FA,stroke:#004080,stroke-width:2px,color:#004080
    classDef step2 fill:#EAF7EA,stroke:#1A661A,stroke-width:2px,color:#1A661A
    classDef step3 fill:#F4EBFA,stroke:#4C1A80,stroke-width:2px,color:#4C1A80
    classDef step4 fill:#FAEFE6,stroke:#994C00,stroke-width:2px,color:#994C00
    classDef step5 fill:#E6ECE6,stroke:#264D26,stroke-width:2px,color:#264D26
    classDef alert fill:#FAE6E6,stroke:#990000,stroke-width:2px,color:#990000

    A[Approach to a Dysmorphic Child]:::step1 --> B[Step 1: History Taking]:::step1
    B --> B1[Pedigree, Antenatal, Perinatal, Developmental]:::step1

    B1 --> C[Step 2: Physical Examination]:::step2
    C --> C1[Systematic head-to-toe anthropometry and assessment]:::step2

    C1 --> D{3 or more minor anomalies?}:::alert
    D -- Yes --> D1[High likelihood of underlying genetic syndrome]:::alert
    D -- No --> E

    D1 --> E[Step 3: Pattern Recognition]:::step3
    E --> E1[Isolated Malformation]:::step3
    E --> E2[Multiple Congenital Anomalies]:::step3
    E --> E3[Recognizable Pattern: Syndrome, Sequence, or Association]:::step3

    E1 --> F[Step 4: Tiered Investigations]:::step4
    E2 --> F
    E3 --> F

    F --> F1{Clinical Indication}:::step4

    F1 -- Developmental delay, dysmorphism, or MCA --> G1[First-Tier: Chromosomal Microarray - CMA]:::step4
    F1 -- Suspected classic aneuploidy --> G2[First-Tier: Conventional Karyotyping]:::step4
    F1 -- Suspected specific microdeletion / microduplication --> G3[Targeted: FISH or MLPA]:::step4
    F1 -- Specific clinical clues --> G4[Ancillary: Imaging and Biochemical]:::step4

    G1 -- Unresolved / Consanguinity / Family History --> G5[Second-Tier: Whole Exome Sequencing - WES]:::step4

    G2 --> H[Step 5: Multidisciplinary Management]:::step5
    G3 --> H
    G4 --> H
    G5 --> H

    H --> H1[Clinical Genetics Referral]:::step5
    H --> H2[Pediatric Subspecialty Care]:::step5
    H --> H3[Corrective Surgical & Developmental Interventions]:::step5
    H --> H4[Syndrome-Specific Surveillance]:::step5

Definition And Objectives

• A dysmorphic child exhibits one or more congenital anomalies or unusual physical features that fall outside the normal phenotypic spectrum for age, sex, and ethnicity.
• These features may occur as isolated defects, multiple congenital anomalies (MCA), or as part of a recognizable pattern such as a syndrome, sequence, association, or field defect.
• The primary objectives of systematic evaluation include establishing a precise diagnosis, detecting life-threatening or correctable anomalies early, providing accurate genetic counseling, and guiding multidisciplinary management and long-term surveillance.

Step 1: History Taking

• Pedigree: Construct a three-generation pedigree emphasizing consanguinity, recurrent miscarriages, neonatal deaths, intellectual disability, or known genetic disorders in relatives.
• Antenatal History: Document maternal age, parity, teratogen exposure (alcohol, anticonvulsants, isotretinoin, TORCH infections), maternal diabetes, and prenatal ultrasound anomalies (intrauterine growth restriction, oligohydramnios, structural defects).
• Perinatal History: Note gestational age, birth weight, Apgar scores, NICU admission, feeding difficulties, and neonatal seizures.
• Developmental And Systemic History: Assess age at attainment of milestones, developmental regression, behavioral issues, recurrent infections, and cardiac or skeletal symptoms.

Step 2: Physical Examination

A systematic head-to-toe assessment is essential to document all findings with precise terminology.

• The presence of three or more minor anomalies significantly increases the likelihood of an underlying genetic syndrome.

Step 3: Pattern Recognition And Classification

• Categorize the findings as an isolated malformation, multiple congenital anomalies, or a recognizable pattern.
• Differentiate between a sequence (a cascade of defects arising from a single primary anomaly, such as Pierre-Robin sequence), an association (non-random co-occurrence of anomalies without a single known etiology, such as VACTERL), and a syndrome (multiple anomalies related by a single genetic or chromosomal etiology, such as Down syndrome or Trisomy 18).

Step 4: Tiered Investigations

Adopt a hypothesis-driven approach, prioritizing least invasive and highest-yield testing.

Step 5: Multidisciplinary Management Planning

• Referral: Facilitate early referral to a clinical geneticist for variant interpretation, syndrome confirmation, and recurrence risk counseling.
• Subspecialty Care: Involve pediatric subspecialists such as cardiologists, neurologists, nephrologists, and orthopedists for comorbidity management.
• Interventions: Plan corrective surgical interventions for clefts, cardiac defects, or limb anomalies, and initiate early developmental therapies (physiotherapy, speech therapy).
• Surveillance: Implement syndrome-specific surveillance protocols (e.g., tumor screening in Beckwith-Wiedemann syndrome, thyroid function monitoring in Down syndrome).